Federal Supply Schedule V797D40284

The provided information describes a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract was awarded to Piramal Critical Care Inc., a subsidiary of Piramal Healthcare, Inc., with a period of performance through June 30, 2027 and a ceiling value of $6,680,000.00. The contract is for the provision of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under the FSS...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to GC Biopharma USA, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through January 14, 2025. The FSS contract is for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. Additionally, a Blanket Purchase Agreement (BPA) was awarded under this FSS contract with a ceiling value of...

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $225,000.00 and a period of performance from September 15, 2024 to September 14, 2029. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, as described in the Federal Supply Schedule. The prime contractor is Athena Bioscience, LLC, a for-profit...

The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Altitude Technologies Inc., doing business as Chinook Medical Gear. The contract is valued at $225,000.00 and has an ultimate completion date of January 31, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. Chinook Medical Gear is an 8(a)...

This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Provepharm Inc., a foreign-owned, self-certified small disadvantaged business organization. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a performance period ending on March 15, 2023. It was awarded on October 10, 2022 and is not set aside...

The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028. The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Millicent U.S., Inc. The contract has a ceiling value of $250,000.00 and a period of performance through April 30, 2025. The contract is for pharmaceutical and hematology-related products under GSA Schedule 65 IB - Drugs, Pharmaceuticals, & Hematology Related Products. As a Federal Supply Schedule contract, it is a multiple award vehicle that allows federal...

This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The $225,000 multiple-award contract has a period of performance from February 15, 2025, to February 14, 2030. The prime contractor for this IDV is Orchard Therapeutics North America, a for-profit, foreign-owned organization. The contract does not utilize any...

The key products and services being delivered under this federal Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc. are a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC, valued at $499,999,999 and valid through November 2026, covers an extensive portfolio of pharmaceutical products including branded and generic prescription drugs, over-the-counter...